The CEO AI Confidence Gap Is Costing Enterprises Billions

CEOs are falling for AI demos while employees inherit the broken workflows. Box CEO Aaron Levie explains why executive distance from last-mile work is the real reason enterprise AI agents fail, and what investors should watch instead.

AI And The Continuum Of Care

AI healthcare panel explores trust, governance, clinician augmentation, cybersecurity, regulation, and medical-grade AI development.

Ray-Ban Meta Blayzer: Everything You Need To Know About Meta’s New Prescription Smart Glasses

The newest smart specs from Ray-Ban Meta are the first designed specifically for prescription wearers. Here’s all you need to know.

Deaths, Burned Clinics – What’s Different About Ebola’s 2026 Return?

12-Yrs ago my Ebola piece was not about it arriving in the US. It was about an era where infectious disease could become a geopolitical & economic force. The era is now.

DNA Is Becoming Programmable. Curing Cancer With AI.

How a startup is curing cancer with AI: Earli writes DNA like text, but the real moat isn’t the model. It’s the proprietary data and human-guided learning loop.

WWDC26: Invite Design Reveals Clues About New Siri Interface, Report Claims

On June 8, Apple will unveil what it has planned for the iPhone, iPad, Mac and Apple Watch. And the invite drops several clues, it seems.

10 Lessons Of Love From The World’s Best Relationship Experts

The ‘Einsteins of love’ spent decades studying thousands of couples. Their findings reveal the everyday behaviors that strengthen relationships over time.

Hermes Agentic AI Overtakes OpenClaw, 10 Shifts Leaders Need To Know

Hermes Agent overtakes OpenClaw as agentic systems accelerate. Learn the 10 key agentic shifts reshaping enterprise strategy, speed, and execution today.

Warning: Four iPhones, Including iPhone 11, May Lose Support In Next iOS Cycle

The next iPhone software cycle, iOS 27, is reported to cancel support for some iPhones. Here’s what you need to know.

GLP-1 Weight Loss Drugs Could Stop Cancer Progressing Says New Study

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tumors including breast and lung